Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Split

65 clinical trials in Split, Croatia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Split at a glance
65
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

65 trials in Split

Open in trial search
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:ADX-324
  • Sponsor:Adarx Pharmaceuticals Inc.
Countries:CroatiaCroatia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:ADX-324
  • Sponsor:Adarx Pharmaceuticals Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Mediar Therapeutics Inc.

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Split

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on autoimmune disorders including trials for new treatments of Sjögren's Syndrome, Systemic Lupus Erythematosus, and Psoriatic Arthritis. Studies are evaluating novel therapeutic approaches to manage symptoms and improve patient outcomes.

  • Systemic Sclerosis Treatment
  • Lupus Nephritis Management
  • Immunological Response Studies
02 Inflammatory Diseases

Comprehensive research into inflammatory conditions, with trials examining treatments for Crohn's Disease and Ulcerative Colitis. Studies are investigating combination therapies and long-term maintenance treatments to improve disease management.

  • Gastrointestinal Disorders
  • Dermatological Conditions
  • Novel Treatment Approaches
03 Neurological Disorders

Advanced clinical trials exploring treatments for Multiple Sclerosis, with studies comparing the efficacy of new medications against established therapies. Research includes both adult and pediatric populations with relapsing-remitting forms of the disease.

  • MS Treatment Innovations
  • Pediatric MS Studies
  • Disease Modification Research
04 Oncology Research

Cutting-edge studies in cancer treatment, including trials for breast cancer and multiple myeloma. Research focuses on targeted therapies and novel treatment combinations to improve patient outcomes.

  • Hematological Malignancies
  • Breast Cancer Therapies
  • Targeted Treatment Approaches
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).